SCHEMBL19343871

SCHEMBL19343871

CN1CCC2(CCCN2C[C@H]2O[C@@H](n3ccc4c(NC(c5ccccc5)c5ccccc5)nccc43)[C@@H]3OC(C)(C)O[C@@H]32)CC1

nearest known ligand 0.44

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ PRMT5 O14744 3/20 0.44
▸ WDR77 Q9BQA1 2/20 0.44
▸ ACHE P22303 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23584548 0.88 PRMT5 (0.36) PRMT5WDR77
SCHEMBL19343823 0.83 PRMT5 (0.48) PRMT5WDR77
SCHEMBL19343867 0.81 PRMT5 (0.44) PRMT5WDR77
SCHEMBL19343825 0.75 PRMT5 (0.61) PRMT5WDR77
SCHEMBL19343845 0.73 PRMT5 (0.49) PRMT5WDR77
SCHEMBL19343829 0.72 PRMT5 (0.50) PRMT5WDR77
SCHEMBL19343880 0.72 PRMT5 (0.58) PRMT5WDR77
SCHEMBL19343817 0.72 PRMT5 (0.57) PRMT5WDR77
SCHEMBL19344011 0.71 PRMT5 (0.75) PRMT5WDR77
SCHEMBL23584564 0.71 PRMT5 (0.38) PRMT5WDR77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3426664-B1 SUBSTITUTED NUCLEOSIDE ANALOGUES FOR USE AS PRMT5 INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2021-06-30 — — EP disclosed
WO-2017153186-A1 SUBSTITUTED NUCLEOSIDE ANALOGUES FOR USE AS PRMT5 INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2017-09-14 — — WO disclosed
Send feedback